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The world is in the midst of a major public health emergency in the form of COVID-19. The 
pandemic, first noted in Wuhan, China, in December 2019 has since spread to nearly all 
countries of the world, with more than 3 million people testing positive for the virus, which 
has caused more than 200,000 deaths (as of 2 May 2020).1 The full impact of the pandemic 
remains unclear as the situation continues to evolve. 
Although the majority of infected people have mild disease, severe pneumonia and 
death occurs in about 7% of affected people.2 People at risk of severe disease and death include 
the elderly and those with comorbid disease states such as hypertension, chronic cardiac 
disease, chronic respiratory disease, chronic kidney disease and diabetes.3–5 However, it is 
worth noting that there are currently no studies from Africa, where in some settings fewer than 
10% of hypoxic patients receive oxygen.6 
Until now, the 46 countries that comprise the WHO African Region have experienced 
a low-level pandemic, with only 0.8% of all global cases and 0.4% of all deaths.2 It is not clear 
why Africa is reporting these low numbers, but the late introduction of the virus at the start of 
the pandemic7,8 and inadequate testing have been advanced as the primary reasons. Although 
case notifications from sub-Saharan Africa (SSA) have not conformed to modelling studies,9 
there is genuine concern that this region could be the fourth epicenter of COVID-19 (after 
China, Europe and the United States), with the full force of the disease hitting Africa in the 
coming months. Others have optimistically suggested that Africa might escape the storm of 
COVID-19. This optimism is based on observations that countries with BCG vaccination 
coverage appear to have a low pandemic level (presumed to be related to non-specific immune 
function enhancement by BCG vaccination),10 while climate11 and the relatively young 
population may also play a role. While we acknowledge that these factors might influence 
disease progression, there is no currently no evidence for or against, and what is being observed 
may simply be the lull before the storm.  
There are many reasons for Africa to urgently prepare for an anticipated COVID-19 
storm. These include the large population that is vulnerable because of existing conditions, 
such as HIV-infected persons (68% of the 37.9 million people living with HIV in the world),12 
alongside the burden of chronic obstructive pulmonary disease,13 diabetes,14 and tuberculosis 
(TB), which may lead to more severe disease.15 The effects of poverty and social deprivation 
(including indoor air pollution, overcrowding, malnutrition, poor access to clean water and 
sub-optimal access to quality health services) may further increase the risk of exposure to 
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infection and or severity of disease, in addition to constraining our ability to fully implement 
measures to limit transmission.  
The weak health care systems in SSA is another reason for concern. Health care worker 
density in SSA is among the lowest in the world and is insufficient to meet the targets of the 
UN Sustainable Development Goals. Specialised personnel that are needed to provide care to 
COVID-19 patients, such as infectious disease specialists, pulmonologists, intensivists and 
critical care nurses, are generally scarce in SSA. The redeployment of health care workers to 
the COVID-19 response could also lead to weakening of primary and secondary health care, 
disrupt service delivery for endemic diseases and further increase population morbidity and 
mortality, especially among children. Furthermore, if senior, experienced physicians fall ill and 
die, the precious legacy of medical educators that has only recently been established will take 
several generations to replace. 
The provision of essential protective equipment for health care workers is likely to be 
a major challenge in SSA where medical product procurement and supply chain management 
systems are weak. Furthermore, the full morbidity and mortality impact of COVID-19 may not 
be known due to sub-optimal health information systems, while the large socio-economic 
inequalities imply the poor will bear the brunt of COVID-19. 
Based on the above summary, it might appear that Africa is unable to protect itself from 
COVID-19. However, with forethought and planning the disaster could be averted and/or 
substantially mitigated (Table).  
First, SSA needs to adopt a collaborative approach to finding, utilising and sharing 
national and regional innovations, highlighting successes and failures including mechanisms 
for coping with the socio-economic consequences of this new disease. These efforts should be 
championed by regional bodies such as the African Union, East African Community, Southern 
Africa Development Community, Eastern, Southern and Central Africa – Health Community 
and Economic Community of West African States.  
Second, the region should rapidly expand testing in both public and private healthcare 
sectors. Tests could be obtained using cost reduction measures such as pooled procurement. 
The region should push for the adoption of existing rapid tests such as the Xpert (Cepheid, 
Sunnyvale, CA, USA) test to expand SARS-COV-2 testing, without compromising testing for 
other diseases. The region should also actively engage in activities related to the development, 
adoption and implementation of rapid antibody-based testing, which have the potential to 




Third, Africa should pay attention to transmission prevention using interventions that 
have been proven to be effective elsewhere, including social or physical distancing, hand 
hygiene, universal use of masks in public, restrictions on travel and gatherings, suspension of 
public transport and closing of schools. 
Fourth, the clinical capacity to provide care to people with COVID-19 needs to be 
expanded rapidly through fast-tracked hiring and training of new health staff, access to oxygen 
at all levels of the health care system, enhancement of patient referral systems and task sharing 
and/or shifting. As attention shifts to the COVID-19 pandemic, it is vitally important that SSA 
continues to provide care for TB, HIV, malaria and emerging non-communicable diseases.  
Finally, we propose that Africa should develop robust collaborative research 
programmes, funded by African governments and partners, to include epidemiological, health 
system, implementation, clinical trials, immunological and virological research.  
Although, the future may appear extremely challenging, Africa can defeat COVID-19. 
The time to act is now.  
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Table  COVID-19 in SSA: key challenges/constraints and mitigation measures 
 
Constraint/challenge  Mitigation measures  Responsible agencies  
Large at-risk populations  Population awareness, targeted 
interventions, epidemiological 
studies to confirm vulnerability  
National Governments/Ministries of 
Health, local and international 
partners  
Inadequate human resource 
for health  
Rapid recruitment and deployment, 
innovative training and support, 
task shifting and sharing, 
telemedicine.  
National Governments/Ministries of 
Health, local and international 
partners  
Weak health products 
procurement and supply 
chain management systems  
Temporary outsourcing of services as 
national systems are strengthened  
National Governments/Ministries of 
Health, local and international 
partners  
Inadequate critical care 
capacity  
Decentralisation of care with emphasis 
on oxygen provision at all levels of 
the health care system, proning, 
clinical guidance with in-built 
flexibility and 
operations/implementation research  
National Governments/Ministries of 
Health, local and international 
partners, research institutions  
Weak health management 
information systems  
Rapid adoption of electronic/digital 
reporting platforms  
National Governments/Ministries of 
Health, local and international 
partners, research institutions 
Disruption of service delivery 
for common endemic 
health problems (HIV, TB, 
malaria, respiratory tract 
infections in children)  
Policy formulation and dissemination, 
health care worker support, 
strengthened infection prevention 
and control, provision of 
appropriate protective equipment  
National Governments/Ministries of 
Health, local and international 
partners, research institutions 
Managing the economic 
consequences of 
lockdowns 
Debt relief, provision highly 
concessional loans, providing 
safety nets for the poor and 
vulnerable 
National Governments, regional and 
international lending institutions, 
development partners  
  
SSA = sub-Saharan Africa; TB = tuberculosis; HIV = human immunodeficiency virus. 
